Genocea Biosciences reported $38.79M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agenus AGEN:US $ 441.3M 24.65M
Baxter International BAX:US $ 32716M 805M
Bluebird Bio BLUE:US $ 491.07M 102.72M
Cytokinetics CYTK:US $ 856.25M 14.93M
Cytori Therapeutics CYTX:US $ 24.52M 2.54M
Genocea Biosciences GNCA:US $ 38.79M 17.18M
Glaxosmithkline GSK:US $ 89689M 10586M
Infinity Pharmaceuticals INFI:US $ 72.58M 12.21M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Moderna Inc MRNA:US 27.61B 2.94B
Novavax NVAX:US $ 2834.88M 258.12M
Prothena PRTA:US $ 581.41M 27.95M